Northern Trust Corp Actinium Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$658 Billion
Q1 2025

A detailed history of Northern Trust Corp transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 228,272 shares of ATNM stock, worth $399,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares

228,272

Previous 251,930 9.39%

Holding current value

$399,476

Previous $317,000 15.77%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$1.06 - $2.12 $25,077 - $50,154	-23,658 Reduced 9.39%	228,272 $367,000
Q4 2024 Feb 14, 2025	BUY	$1.12 - $1.93 $13,229 - $22,797	11,812 Added 4.92%	251,930 $317,000
Q3 2024 Nov 13, 2024	BUY	$1.72 - $8.0 $20,053 - $93,272	11,659 Added 5.1%	240,118 $451,000
Q2 2024 Aug 14, 2024	SELL	$6.56 - $9.89 $14,077 - $21,223	-2,146 Reduced 0.93%	228,459 $1.69 Million
Q1 2024 May 14, 2024	BUY	$5.0 - $9.2 $21,065 - $38,759	4,213 Added 1.86%	230,605 $1.81 Million
Q4 2023 Feb 13, 2024	BUY	$4.02 - $6.08 $24,152 - $36,528	6,008 Added 2.73%	226,392 $1.15 Million
Q3 2023 Nov 13, 2023	BUY	$5.91 - $7.37 $6,193 - $7,723	1,048 Added 0.48%	220,384 $1.3 Million
Q2 2023 Aug 11, 2023	BUY	$7.15 - $9.39 $1.25 Million - $1.64 Million	174,776 Added 392.23%	219,336 $1.63 Million
Q1 2023 May 15, 2023	SELL	$8.51 - $14.26 $1,906 - $3,194	-224 Reduced 0.5%	44,560 $421,000
Q4 2022 Feb 13, 2023	BUY	$7.05 - $14.41 $39,134 - $79,989	5,551 Added 14.15%	44,784 $476,000
Q3 2022 Nov 14, 2022	BUY	$4.81 - $8.48 $5,670 - $9,997	1,179 Added 3.1%	39,233 $289,000
Q2 2022 Aug 12, 2022	BUY	$4.71 - $7.11 $3,221 - $4,863	684 Added 1.83%	38,054 $183,000
Q1 2022 May 13, 2022	SELL	$4.57 - $6.4 $2,815 - $3,942	-616 Reduced 1.62%	37,370 $191,000
Q4 2021 Feb 08, 2022	SELL	$6.01 - $8.8 $2,061 - $3,018	-343 Reduced 0.89%	37,986 $229,000
Q3 2021 Nov 15, 2021	BUY	$5.76 - $9.67 $1,595 - $2,678	277 Added 0.73%	38,329 $339,000
Q2 2021 Aug 13, 2021	BUY	$7.01 - $8.63 $76,759 - $94,498	10,950 Added 40.4%	38,052 $301,000
Q1 2021 May 12, 2021	SELL	$7.62 - $9.79 $1,661 - $2,134	-218 Reduced 0.8%	27,102 $207,000
Q4 2020 Feb 11, 2021	BUY	$7.8 - $12.64 $2,932 - $4,752	376 Added 1.4%	27,320 $213,000
Q3 2020 Nov 16, 2020	BUY	$7.26 - $18.0 $195,613 - $484,992	26,944 New	26,944 $261,000

Others Institutions Holding ATNM

# of Institutions

Shares Held

8.18M

Call Options Held

51.9K

Put Options Held

6.2K

View Full List

About Actinium Pharmaceuticals, Inc.

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $44.1M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

More about ATNM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Actinium Pharmaceuticals, Inc. Transaction History